Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy
Ct. Yiannoutsos et al., Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy, ANN NEUROL, 45(6), 1999, pp. 816-820
The detection and semiquantitation of JC virus (JCV) DNA in cerebrospinal f
luid (CSF) is prognostic of survival and is a marker of the course of progr
essive multifocal leukoencephalopathy (PML). CSF samples from 15 acquired i
mmunodeficiency syndrome (AIDS) patients with biopsy-proven PML were analyz
ed by semiquantitative polymerase chain reaction (PCR). A low JCV burden wa
s predictive of longer survival compared with a high JCV burden (median sur
vival from entry, 24 [2-63] vs 7.6 [4-17] weeks). Further analyses indicate
d a possible threshold of 50 to 100 copies/mu l separating high- and modera
te-risk cases. Patients with a JCV load below this level survived longer th
an those with a JCV load above it.